Cargando…
Correction: Coppock et al. Pharmacologic Ascorbic Acid as Early Therapy for Hospitalized Patients with COVID-19: A Randomized Clinical Trial. Life 2022, 12, 453
Autores principales: | Coppock, Dagan, Violet, Pierre-Christian, Vasquez, Gustavo, Belden, Katherine, Foster, Michael, Mullin, Bret, Magee, Devon, Mikell, Isabelle, Shah, Lokesh, Powers, Victoria, Curcio, Brian, Monti, Daniel, Levine, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504031/ https://www.ncbi.nlm.nih.gov/pubmed/36143494 http://dx.doi.org/10.3390/life12091354 |
Ejemplares similares
-
Pharmacologic Ascorbic Acid as Early Therapy for Hospitalized Patients with COVID-19: A Randomized Clinical Trial
por: Coppock, Dagan, et al.
Publicado: (2022) -
Pharmacologic Ascorbate in Myeloma Treatment: Doses Matter
por: Violet, Pierre-Christian, et al.
Publicado: (2017) -
Structural analysis of the mutant protein D26G of human γS-crystallin, associated with Coppock cataract
por: Karri, Srinivasu, et al.
Publicado: (2013) -
A novel mutation in GJA3 associated with congenital Coppock-like cataract in a large Chinese family
por: Zhang, Lu, et al.
Publicado: (2012) -
Séminaire Bourbaki : exposés 453–470
por: Collective
Publicado: (1976)